Schisandrin B Targets PXR to Enhance Bile Acid Metabolism and Alleviate ANIT-Induced Cholestatic Liver Injury via Dual Pathways. [PDF]
Zhang Y +9 more
europepmc +1 more source
Schisandrin B Induced ROS-Mediated Autophagy and Th1/Th2 Imbalance via Selenoproteins in Hepa1-6 Cells. [PDF]
Tan S +5 more
europepmc +1 more source
Schisandrin B Alleviates Lipid Metabolism Disorders and Apoptosis of MAFLD via Modulation of PPARγ-PCK1 and Caspase-3 Signaling Pathways. [PDF]
Gao M +7 more
europepmc +1 more source
Schisandrin B regulates macrophage polarization and alleviates liver fibrosis via activation of PPARγ. [PDF]
Chen Q +6 more
europepmc +1 more source
Schisandrin B alleviates metabolic associated fatty liver disease by regulating the PPARγ signaling pathway and gut microbiota in mice. [PDF]
Wan J +7 more
europepmc +1 more source
Potential protective benefits of Schisandrin B against severe acute hepatitis in children during the COVID-19 pandemic based on a network pharmacology analysis. [PDF]
Fang Y +4 more
europepmc +1 more source
RETRACTED: Xiang et al. Schisandrin B Induces Apoptosis and Cell Cycle Arrest of Gallbladder Cancer Cells. <i>Molecules</i> 2014, <i>19</i>, 13235-13250. [PDF]
Xiang SS +18 more
europepmc +1 more source
Ameliorative effects of Schisandrin B on Schistosoma mansoni-induced hepatic fibrosis in vivo. [PDF]
Lam HYP, Liang TR, Peng SY.
europepmc +1 more source
Schisandrin B downregulates exosomal fibronectin 1 expression to inhibit hepatocellular carcinoma growth. [PDF]
Jiang B +8 more
europepmc +1 more source
Study on the Role of Schisandrin B in Ameliorating Hepatic Ischemia-Reperfusion Injury by Modulating Hepatocyte Autophagy. [PDF]
Fei Z, Haihang P, Xueyang C, Miao S.
europepmc +1 more source

